Ottimo Pharma
Developer of cancer therapeutics designed to treat solid tumors. The company offers a bi-functional antibody that targets both immune checkpoint inhibition and angiogenesis which are pathways involved...
Valuation
$242.4M
Market implied
Share Price
N/A
Total Raised
$149.7M
Last Round
N/A